武汉科斯坦生物科技有限公司
服务热线:15926423062
产品展厅
Ceritinib(LDK378)
  • 品牌:Chemstan
  • 产地:中国
  • 货号:LC-01
  • cas:1032900-25-6
  • 价格: ¥800/支
  • 发布日期: 2019-11-26
  • 更新日期: 2025-09-25
产品详请
产地 中国
品牌 Chemstan
货号 LC-01
用途 中间体
包装规格 20mg
纯度 98%%
CAS编号 1032900-25-6
是否进口

联合知名大学科研院所及企业开发药食两用植物标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,小分子化合物库,药物杂质。所有产品仅用作科学研究,我们不为任何个人用途提供产品和服务。


常用名色瑞替尼 英文名Ceritinib
CAS号1032900-25-6 分子量558.135
密度1.3±0.1 g/cm3沸点720.7±70.0 °C at 760 mmHg
分子式C28H36ClN5O3S熔点N/A
MSDSN/A闪点389.6±35.7 °C


色瑞替尼用途:

 

Ceritinib (LDK378) 是有效且特异性的 ALK 抑制剂,IC50 为 0.2 nM。


Fields of Application : 
LDK378 is a highly selective ALK inhibitor with IC50 of 2 nM

CAS Number:1032900-25-6
Purity:

>99%

Molecular Weight:558.14
Molecular Formula:C28H36ClN5O3S

Quality Control: HPLC、NMR、 LC/MS(Please contact us to get the QC report)

Synonyms:LDK-378; LDK378,Ceritinib
Chemical Name:5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
Storage:2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO

Note: Products for research use only, not for human use

Description:
LDK378 is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC). In Phase I trials, LDK378 showed a marked clinical response in 78 patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during or after crizotinib therapy or had not been previously treated with crizotinib.For the detailed information of LDK378 (ALK1 inhibitor), the solubility of LDK378 (ALK1 inhibitor) in water, the solubility of LDK378 (ALK1 inhibitor) in DMSO, the solubility of LDK378 (ALK1 inhibitor) in PBS buffer, the animal experiment (test) of LDK378 (ALK1 inhibitor), the cell expriment (test) of LDK378 (ALK1 inhibitor), the in vivo, in vitro and clinical trial test of LDK378 (ALK1 inhibitor), the EC50, IC50,and Affinity of LDK378 (ALK1 inhibitor), Please contact DC Chemicals.


联系方式
手机:15926423062
手机访问官网